Moors & Cabot’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $560K | Sell |
8,014
-22
| -0.3% | -$1.54K | 0.03% | 479 |
|
|
2025
Q1 | $591K | Sell |
8,036
-55
| -0.7% | -$4.04K | 0.03% | 441 |
|
|
2024
Q4 | $530K | Buy |
8,091
+900
| +13% | +$59K | 0.03% | 489 |
|
|
2024
Q3 | $560K | Buy |
7,191
+121
| +2% | +$9.43K | 0.03% | 470 |
|
|
2024
Q2 | $551K | Sell |
7,070
-1,365
| -16% | -$106K | 0.03% | 455 |
|
|
2024
Q1 | $571K | Buy |
8,435
+11
| +0.1% | +$745 | 0.03% | 456 |
|
|
2023
Q4 | $567K | Buy |
8,424
+58
| +0.7% | +$3.91K | 0.04% | 426 |
|
|
2023
Q3 | $567K | Buy |
8,366
+340
| +4% | +$23K | 0.04% | 397 |
|
|
2023
Q2 | $574K | Sell |
8,026
-2,778
| -26% | -$199K | 0.04% | 403 |
|
|
2023
Q1 | $750K | Buy |
10,804
+43
| +0.4% | +$2.98K | 0.05% | 324 |
|
|
2022
Q4 | $730K | Buy |
10,761
+177
| +2% | +$12K | 0.05% | 331 |
|
|
2022
Q3 | $580K | Sell |
10,584
-545
| -5% | -$29.9K | 0.04% | 352 |
|
|
2022
Q2 | $735K | Buy |
11,129
+288
| +3% | +$19K | 0.05% | 326 |
|
|
2022
Q1 | $719K | Buy |
10,841
+292
| +3% | +$19.4K | 0.04% | 369 |
|
|
2021
Q4 | $614K | Buy |
10,549
+554
| +6% | +$32.2K | 0.04% | 402 |
|
|
2021
Q3 | $600K | Sell |
9,995
-365
| -4% | -$21.9K | 0.04% | 396 |
|
|
2021
Q2 | $621K | Sell |
10,360
-785
| -7% | -$47.1K | 0.04% | 367 |
|
|
2021
Q1 | $554K | Sell |
11,145
-153
| -1% | -$7.61K | 0.04% | 374 |
|
|
2020
Q4 | $563K | Buy |
11,298
+297
| +3% | +$14.8K | 0.05% | 337 |
|
|
2020
Q3 | $603K | Sell |
11,001
-2,420
| -18% | -$133K | 0.06% | 294 |
|
|
2020
Q2 | $706K | Sell |
13,421
-74
| -0.5% | -$3.89K | 0.08% | 244 |
|
|
2020
Q1 | $600K | Sell |
13,495
-1,637
| -11% | -$72.8K | 0.09% | 214 |
|
|
2019
Q4 | $756K | Buy |
15,132
+121
| +0.8% | +$6.05K | 0.08% | 243 |
|
|
2019
Q3 | $665K | Buy |
15,011
+148
| +1% | +$6.56K | 0.07% | 263 |
|
|
2019
Q2 | $615K | Buy |
14,863
+2,783
| +23% | +$115K | 0.08% | 259 |
|
|
2019
Q1 | $488K | Buy |
12,080
+1,229
| +11% | +$49.6K | 0.07% | 283 |
|
|
2018
Q4 | $410K | Sell |
10,851
-300
| -3% | -$11.3K | 0.06% | 291 |
|
|
2018
Q3 | $442K | Sell |
11,151
-22
| -0.2% | -$872 | 0.05% | 338 |
|
|
2018
Q2 | $396K | Sell |
11,173
-1,343
| -11% | -$47.6K | 0.05% | 350 |
|
|
2018
Q1 | $438K | Buy |
12,516
+140
| +1% | +$4.9K | 0.06% | 356 |
|
|
2017
Q4 | $427K | Sell |
12,376
-2,379
| -16% | -$82.1K | 0.06% | 349 |
|
|
2017
Q3 | $501K | Sell |
14,755
-3,185
| -18% | -$108K | 0.07% | 307 |
|
|
2017
Q2 | $610K | Buy |
17,940
+700
| +4% | +$23.8K | 0.1% | 249 |
|
|
2017
Q1 | $533K | Buy |
17,240
+1,012
| +6% | +$31.3K | 0.09% | 264 |
|
|
2016
Q4 | $441K | Buy |
16,228
+1,300
| +9% | +$35.3K | 0.07% | 312 |
|
|
2016
Q3 | $492K | Buy |
14,928
+3,566
| +31% | +$118K | 0.08% | 272 |
|
|
2016
Q2 | $340K | Sell |
11,362
-1,650
| -13% | -$49.4K | 0.06% | 343 |
|
|
2016
Q1 | $364K | Buy |
13,012
+177
| +1% | +$4.95K | 0.07% | 307 |
|
|
2015
Q4 | $438K | Buy |
12,835
+100
| +0.8% | +$3.41K | 0.08% | 278 |
|
|
2015
Q3 | $407K | Sell |
12,735
-987
| -7% | -$31.5K | 0.08% | 294 |
|
|
2015
Q2 | $440K | Buy |
13,722
+500
| +4% | +$16K | 0.07% | 299 |
|
|
2015
Q1 | $452K | Buy |
13,222
+622
| +5% | +$21.3K | 0.08% | 287 |
|
|
2014
Q4 | $443K | Buy |
12,600
+3,100
| +33% | +$109K | 0.08% | 287 |
|
|
2014
Q3 | $336K | Hold |
9,500
| – | – | 0.06% | 347 |
|
|
2014
Q2 | $351K | Sell |
9,500
-1,400
| -13% | -$51.7K | 0.06% | 342 |
|
|
2014
Q1 | $354K | Buy |
+10,900
| New | +$354K | 0.09% | 243 |
|